Report Netherlands - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update: Sep 1, 2023

Netherlands - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)

Netherlands: Medicaments Containing Insulin Market 2023

Medicaments Containing Insulin Market Size in the Netherlands

The Dutch medicaments containing insulin market soared to $X in 2021, jumping by 25,131% against the previous year. Over the period under review, consumption recorded strong growth. Over the period under review, the market reached the maximum level at $X in 2019; however, from 2020 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production in the Netherlands

In value terms, medicaments containing insulin production stood at $X in 2021 estimated in export price. Over the period under review, production continues to indicate a sharp decrease. The pace of growth appeared the most rapid in 2019 with a decrease of -11.8% against the previous year. Over the period under review, production reached the maximum level at $X in 2017; however, from 2018 to 2021, production remained at a lower figure.

Medicaments Containing Insulin Exports

Exports from the Netherlands

In 2021, approx. X kg of medicaments containing insulin but not antibiotics were exported from the Netherlands; waning by -50.5% on the previous year. In general, exports recorded a dramatic decrease. The smallest decline of -37.9% was in 2019. The exports peaked at X tons in 2017; however, from 2018 to 2021, the exports failed to regain momentum.

In value terms, medicaments containing insulin exports surged to $X in 2021. Overall, exports showed a dramatic slump. Over the period under review, the exports attained the maximum at $X in 2017; however, from 2018 to 2021, the exports remained at a lower figure.

Exports by Country

The UK (X kg) was the main destination for medicaments containing insulin exports from the Netherlands, with a 63% share of total exports. Moreover, medicaments containing insulin exports to the UK exceeded the volume sent to the second major destination, the Czech Republic (X kg), fivefold. Germany (X kg) ranked third in terms of total exports with a 7.4% share.

From 2017 to 2021, the average annual rate of growth in terms of volume to the UK stood at +652.4%. Exports to the other major destinations recorded the following average annual rates of exports growth: the Czech Republic (+87.1% per year) and Germany (-86.0% per year).

In value terms, the UK ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics exports from the Netherlands, comprising 71% of total exports. The second position in the ranking was held by the Czech Republic ($X), with a 15% share of total exports. It was followed by Poland, with a 9.6% share.

From 2017 to 2021, the average annual rate of growth in terms of value to the UK stood at +6,321.5%. Exports to the other major destinations recorded the following average annual rates of exports growth: the Czech Republic (+538.6% per year) and Poland (+10.9% per year).

Export Prices by Country

In 2021, the average medicaments containing insulin export price amounted to $X per ton, rising by 433% against the previous year. In general, the export price saw a significant expansion. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices for the major overseas markets. In 2021, amid the top suppliers, the country with the highest price was Poland ($X per ton), while the average price for exports to Germany ($X per ton) was amongst the lowest.

From 2017 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Poland (+1,370.2%), while the prices for the other major destinations experienced more modest paces of growth.

Medicaments Containing Insulin Imports

Imports into the Netherlands

In 2021, the amount of medicaments containing insulin but not antibiotics imported into the Netherlands skyrocketed to X tons, with an increase of 20% against 2020. Over the period under review, imports showed a relatively flat trend pattern. The pace of growth appeared the most rapid in 2019 when imports increased by 1,876% against the previous year. As a result, imports attained the peak of X tons. From 2020 to 2021, the growth of imports remained at a somewhat lower figure.

In value terms, medicaments containing insulin imports reduced remarkably to $X in 2021. Overall, imports continue to indicate a remarkable increase. The most prominent rate of growth was recorded in 2019 with an increase of 2,192%. As a result, imports reached the peak of $X. From 2020 to 2021, the growth of imports failed to regain momentum.

Imports by Country

In 2021, Belgium (X tons) constituted the largest supplier of medicaments containing insulin to the Netherlands, accounting for a 90% share of total imports. Moreover, medicaments containing insulin imports from Belgium exceeded the figures recorded by the second-largest supplier, the UK (X kg), more than tenfold.

From 2012 to 2021, the average annual rate of growth in terms of volume from Belgium amounted to -55.2%. The remaining supplying countries recorded the following average annual rates of imports growth: the UK (0.0% per year) and Estonia (-32.1% per year).

In value terms, Belgium ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to the Netherlands, comprising 78% of total imports. The second position in the ranking was held by Estonia ($X), with a 15% share of total imports.

From 2012 to 2021, the average annual growth rate of value from Belgium amounted to -40.8%. The remaining supplying countries recorded the following average annual rates of imports growth: Estonia (-11.8% per year) and the UK (0.0% per year).

Import Prices by Country

In 2021, the average medicaments containing insulin import price amounted to $X per ton, reducing by -68.5% against the previous year. Over the period under review, the import price, however, enjoyed a remarkable increase. The pace of growth appeared the most rapid in 2020 when the average import price increased by 454% against the previous year. As a result, import price reached the peak level of $X per ton, and then shrank dramatically in the following year.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Estonia ($X per ton), while the price for the UK ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Belgium (+32.1%).

Source: IndexBox Platform

Base Year Historical Period Forecast Period Units
2022 2012-2022 2023-2030 US$, Tons

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in the world?
+
The countries with the highest volumes of consumption in 2021 were the United States, Denmark and Germany, with a combined 72% share of global consumption.
What are the largest producers of medicaments containing insulin but not antibiotics in the world?
+
The country with the largest volume of medicaments containing insulin production was the United States, accounting for 67% of total volume. Moreover, medicaments containing insulin production in the United States exceeded the figures recorded by the second-largest producer, Germany, fivefold. India ranked third in terms of total production with a 5% share.
What are the leading suppliers of medicaments containing insulin but not antibiotics to the Netherlands?
+
In value terms, Belgium constituted the largest supplier of medicaments containing insulin but not antibiotics to the Netherlands, comprising 78% of total imports. The second position in the ranking was taken by Estonia, with a 15% share of total imports.
What are the leading importers of medicaments containing insulin but not antibiotics from the Netherlands?
+
In value terms, the UK emerged as the key foreign market for medicaments containing insulin but not antibiotics exports from the Netherlands, comprising 71% of total exports. The second position in the ranking was held by the Czech Republic, with a 15% share of total exports. It was followed by Poland, with a 9.6% share.
What is the average export price for medicaments containing insulin but not antibiotics in the Netherlands?
+
In 2021, the average medicaments containing insulin export price amounted to $362,895 per ton, picking up by 433% against the previous year.
What is the average import price for medicaments containing insulin but not antibiotics in the Netherlands?
+
In 2021, the average medicaments containing insulin import price amounted to $27,018 per ton, declining by -68.5% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in the Netherlands. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.


Product coverage:
• Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale
Country coverage:
• Netherlands

Data coverage:
• Market volume and value
• Per Capita consumption
• Forecast of the market dynamics in the medium term
• Trade (exports and imports) in the Netherlands
• Export and import prices
• Market trends, drivers and restraints
• Key market players and their profiles

Reasons to buy this report:
• Take advantage of the latest data
• Find deeper insights into current market developments
• Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:
1. How to diversify your business and benefit from new market opportunities
2. How to load your idle production capacity
3. How to boost your sales on overseas markets
4. How to increase your profit margins
5. How to make your supply chain more sustainable
6. How to reduce your production and supply chain costs
7. How to outsource production to other countries
8. How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business

1.1
REPORT DESCRIPTION
1.2
RESEARCH METHODOLOGY AND AI PLATFORM
1.3
DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
1.4
REPORT DESCRIPTION
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance

3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects

3.1
MARKET SIZE
3.2
MARKET STRUCTURE
3.3
TRADE BALANCE
3.4
PER CAPITA CONSUMPTION
3.5
MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business

4.1
TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
4.2
BEST-SELLING PRODUCTS
4.3
MOST CONSUMED PRODUCT
4.4
MOST TRADED PRODUCT
4.5
MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain

5.1
TOP COUNTRIES TO SOURCE YOUR PRODUCT
5.2
TOP PRODUCING COUNTRIES
5.3
TOP EXPORTING COUNTRIES
5.4
LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports

6.1
TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
6.2
TOP CONSUMING MARKETS
6.3
UNSATURATED MARKETS
6.4
TOP IMPORTING MARKETS
6.5
MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry

7.1
PRODUCTION VOLUME AND VALUE
8. IMPORTS

The Largest Import Supplying Countries

8.1
IMPORTS FROM 2012–2022
8.2
IMPORTS BY COUNTRY
8.3
IMPORT PRICES BY COUNTRY
9. EXPORTS

The Largest Destinations for Exports

9.1
EXPORTS FROM 2012–2022
9.2
EXPORTS BY COUNTRY
9.3
EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles

LIST OF TABLES
Table 1:
Key Findings In 2022
Table 2:
Market Volume, In Physical Terms, 2012–2022
Table 3:
Market Value, 2012–2022
Table 4:
Per Capita Consumption In 2012-2022
Table 5:
Imports, In Physical Terms, By Country, 2012–2022
Table 6:
Imports, In Value Terms, By Country, 2012–2022
Table 7:
Import Prices, By Country Of Origin, 2012–2022
Table 8:
Exports, In Physical Terms, By Country, 2012–2022
Table 9:
Exports, In Value Terms, By Country, 2012–2022
Table 10:
Export Prices, By Country Of Destination, 2012–2022
LIST OF FIGURES
Figure 1:
Market Volume, In Physical Terms, 2012–2022
Figure 2:
Market Value, 2012–2022
Figure 3:
Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2022
Figure 4:
Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2022
Figure 5:
Trade Balance, In Physical Terms, 2012-2022
Figure 6:
Trade Balance, In Value Terms, 2012-2022
Figure 7:
Per Capita Consumption, 2012-2022
Figure 8:
Market Volume Forecast to 2030
Figure 9:
Market Value Forecast to 2030
Figure 10:
Products: Market Size And Growth, By Type
Figure 11:
Products: Average Per Capita Consumption, By Type
Figure 12:
Products: Exports And Growth, By Type
Figure 13:
Products: Export Prices And Growth, By Type
Figure 14:
Production Volume And Growth
Figure 15:
Exports And Growth
Figure 16:
Export Prices And Growth
Figure 17:
Market Size And Growth
Figure 18:
Per Capita Consumption
Figure 19:
Imports And Growth
Figure 20:
Import Prices
Figure 21:
Production, In Physical Terms, 2012–2022
Figure 22:
Production, In Value Terms, 2012–2022
Figure 23:
Imports, In Physical Terms, 2012–2022
Figure 24:
Imports, In Value Terms, 2012–2022
Figure 25:
Imports, In Physical Terms, By Country, 2022
Figure 26:
Imports, In Physical Terms, By Country, 2012–2022
Figure 27:
Imports, In Value Terms, By Country, 2012–2022
Figure 28:
Import Prices, By Country Of Origin, 2012–2022
Figure 29:
Exports, In Physical Terms, 2012–2022
Figure 30:
Exports, In Value Terms, 2012–2022
Figure 31:
Exports, In Physical Terms, By Country, 2022
Figure 32:
Exports, In Physical Terms, By Country, 2012–2022
Figure 33:
Exports, In Value Terms, By Country, 2012–2022
Figure 34:
Export Prices, By Country Of Destination, 2012–2022
Webinar: Decarbonisation and Your Business Strategy - Zero Net Carbon Buildings

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 22nd, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Tools and Marketplaces

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 8th, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Steps and Practices

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, January 25th, 2022 @ 04:00 pm ET